It was announced on May 10, 2022 in Ottawa, Ontario /PRNewswire.- A licensing agreement has been signed between Tetra Bio-Pharma Inc. and True North Cannabis Corp., a leading cannabinoid-derived drug discovery and development company, allowing True North to use Tetra’s highly innovative proprietary liposome encapsulation technology in formulations distributed under the True North brand. Tetra Bio-Pharma Inc.
A variety of CBD products benefit from Tetra’s exclusive technology, which enhances absorption and emulsification in the body. It is expected that Panag and the True North product team will work together to integrate this technology and create a line of hemp-derived CBD formulations that True North and its partners will commercialize through their existing distribution relationships in Canada’s medical and recreational markets.
Also read: cofinitive has been named to PRWeek’s elite